Welcome to MyStrategist

Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today

Subscribe Browse

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review

Trial MyStrategist.com and unlock 7-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial

Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Start-Ups

PolyVascular: Synthetic Valve Implants for Congenital Heart Defects

Though congenital heart defects are a leading cause of childhood fatalities, there are no prosthetic valves for transcatheter use in young children. PolyVascular seeks to change this with a polymer-based transcatheter valve that could spare patients one or more open surgeries.

Don't Just Advertise... Strategize!

Advertise with MedTech Strategist and be seen by medtech's most influential executives.

Learn More

Latest from Community Blog

MedTech Strategist's free Community Blog explores the passion behind the people, technologies, and companies impacting the global device space.

Perspective & Commentary

Market Pathways Top Five: September 2021

The top five Market Pathways articles posted in September to MyStrategist.com, chosen by readers and editors, include CMS’ proposed repeal of the MCIT rule, getting reimbursement for AI tech, Doc Depot, our Q&A with MDIC’s new VP of Health Economics & Patient Value, and robust regulatory activity in Asia.

Our strategic publications provide actionable intelligence to support each member of your organization. Check to see if your company has access.

Learn More